Celestica Financials
This page shows Celestica (CLS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Celestica has an operating margin of 6.2%, meaning the company retains $6 of operating profit per $100 of revenue. This results in a moderate score of 31/100, indicating healthy but not exceptional operating efficiency. This is up from 4.3% the prior year.
Celestica's revenue surged 21.2% year-over-year to $9.6B, reflecting rapid business expansion. This strong growth earns a score of 89/100.
Celestica carries a low D/E ratio of 0.41, meaning only $0.41 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 96/100, indicating a strong balance sheet with room for future borrowing.
Celestica's current ratio of 1.49 indicates adequate short-term liquidity, earning a score of 40/100. The company can meet its near-term obligations, though with limited headroom.
Celestica's free cash flow margin of 3.1% results in a low score of 16/100. Capital expenditures of $170.9M absorb a large share of operating cash flow.
Celestica earns a strong 22.6% return on equity (ROE), meaning it generates $23 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 90/100. This is up from 13.8% the prior year.
Celestica scores 7.05, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($33.5B) relative to total liabilities ($4.1B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Celestica passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Celestica generates $1.11 in operating cash flow ($473.9M OCF vs $428.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Celestica earns $11.5 in operating income for every $1 of interest expense ($599.3M vs $52.1M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Celestica generated $9.6B in revenue in fiscal year 2024. This represents an increase of 21.2% from the prior year.
Celestica's EBITDA was $751.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 60.1% from the prior year.
Celestica generated $303.0M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 50.7% from the prior year.
Celestica reported $428.0M in net income in fiscal year 2024. This represents an increase of 75.1% from the prior year.
Celestica earned $3.61 per diluted share (EPS) in fiscal year 2024. This represents an increase of 77.8% from the prior year.
Celestica held $423.3M in cash against $770.2M in long-term debt as of fiscal year 2024.
Celestica's gross margin was 10.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 1.2 percentage points from the prior year.
Celestica's operating margin was 6.2% in fiscal year 2024, reflecting core business profitability. This is up 2.0 percentage points from the prior year.
Celestica's net profit margin was 4.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 1.4 percentage points from the prior year.
Celestica's ROE was 22.6% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 8.8 percentage points from the prior year.
Celestica invested $78.0M in research and development in fiscal year 2024. This represents an increase of 28.1% from the prior year.
Celestica spent $152.0M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 327.0% from the prior year.
Celestica invested $170.9M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 36.6% from the prior year.
CLS Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|
| Revenue | $3.2B+10.4% | $2.9B+9.2% | $2.6B+4.0% | $2.5B+6.4% | $2.4B+8.3% | $2.2B | N/A |
| Cost of Revenue | $2.8B+10.1% | $2.5B+6.2% | $2.4B+5.6% | $2.2B+5.2% | $2.1B+7.6% | $2.0B | N/A |
| Gross Profit | $416.1M+12.2% | $371.0M+35.5% | $273.9M-7.8% | $297.2M+17.1% | $253.8M+14.3% | $222.1M | N/A |
| R&D Expenses | $36.4M+7.1% | $34.0M+93.2% | $17.6M-24.8% | $23.4M+20.6% | $19.4M+17.6% | $16.5M | N/A |
| SG&A Expenses | $38.4M-1.3% | $38.9M-65.4% | $112.5M+95.3% | $57.6M-27.4% | $79.3M+22.4% | $64.8M | N/A |
| Operating Income | $325.0M+19.3% | $272.5M+111.6% | $128.8M-36.4% | $202.6M+52.4% | $132.9M+5.6% | $125.8M | N/A |
| Interest Expense | $12.8M-5.2% | $13.5M-1.5% | $13.7M+15.1% | $11.9M-20.7% | $15.0M+7.1% | $14.0M | N/A |
| Income Tax | $43.1M-6.9% | $46.3M+68.4% | $27.5M-27.2% | $37.8M+104.3% | $18.5M+38.1% | $13.4M | N/A |
| Net Income | $267.8M+26.9% | $211.0M+144.8% | $86.2M-43.2% | $151.7M+59.7% | $95.0M+3.5% | $91.8M | N/A |
| EPS (Diluted) | $2.31+26.9% | $1.82+145.9% | $0.74-42.6% | $1.29+61.2% | $0.80+3.9% | $0.77 | N/A |
CLS Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|
| Total Assets | $6.6B+5.9% | $6.2B+7.0% | $5.8B-2.6% | $6.0B | N/A | N/A | $5.9B |
| Current Assets | $5.1B+7.8% | $4.8B+9.0% | $4.4B-3.0% | $4.5B | N/A | N/A | $4.5B |
| Cash & Equivalents | $305.9M-2.5% | $313.8M+3.6% | $303.0M-28.4% | $423.3M-2.5% | $434.0M+40.9% | $308.1M-16.8% | $370.4M |
| Inventory | $2.0B+6.7% | $1.9B+7.3% | $1.8B+1.6% | $1.8B | N/A | N/A | $2.1B |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $340.7M0.0% | $340.8M+0.1% | $340.5M0.0% | $340.5M | N/A | N/A | $321.7M |
| Total Liabilities | $4.6B+2.1% | $4.5B+4.8% | $4.3B+4.5% | $4.1B | N/A | N/A | $4.1B |
| Current Liabilities | $3.5B+5.5% | $3.3B+8.7% | $3.1B+1.1% | $3.0B | N/A | N/A | $3.2B |
| Long-Term Debt | $756.7M-10.8% | $848.6M-7.3% | $915.0M+18.8% | $770.2M | N/A | N/A | $648.3M |
| Total Equity | $2.0B+15.4% | $1.8B+12.9% | $1.6B-17.9% | $1.9B+5.4% | $1.8B+5.2% | $1.7B-3.5% | $1.8B |
| Retained Earnings | N/A | N/A | N/A | -$423.8M | N/A | N/A | -$851.8M |
CLS Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $126.2M-17.2% | $152.4M+17.0% | $130.3M-9.1% | $143.4M+44.0% | $99.6M-7.9% | $108.1M | N/A |
| Capital Expenditures | $37.3M+14.8% | $32.5M-11.4% | $36.7M-22.9% | $47.6M+29.0% | $36.9M-8.7% | $40.4M | N/A |
| Free Cash Flow | $88.9M-25.9% | $119.9M+28.1% | $93.6M-2.3% | $95.8M+52.8% | $62.7M-7.4% | $67.7M | N/A |
| Investing Cash Flow | -$37.3M-6.6% | -$35.0M+4.6% | -$36.7M+28.0% | -$51.0M+27.2% | -$70.1M-73.5% | -$40.4M | N/A |
| Financing Cash Flow | -$96.8M+9.2% | -$106.6M+50.2% | -$213.9M-216.4% | -$67.6M-170.1% | $96.4M+174.2% | -$130.0M | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $0-100.0% | $40.0M-48.5% | $77.7M+204.7% | $25.5M+155.0% | $10.0M-39.4% | $16.5M | N/A |
CLS Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 13.0%+0.2pp | 12.8%+2.5pp | 10.3%-1.3pp | 11.7%+1.1pp | 10.6%+0.6pp | 10.1% | N/A |
| Operating Margin | 10.2%+0.8pp | 9.4%+4.6pp | 4.9%-3.1pp | 8.0%+2.4pp | 5.6%-0.1pp | 5.7% | N/A |
| Net Margin | 8.4%+1.1pp | 7.3%+4.0pp | 3.3%-2.7pp | 6.0%+2.0pp | 4.0%-0.2pp | 4.2% | N/A |
| Return on Equity | 13.2%+1.2pp | 12.0%+6.5pp | 5.5%-2.5pp | 8.0%+2.7pp | 5.3%-0.1pp | 5.4% | N/A |
| Return on Assets | 4.0%+0.7pp | 3.4%+1.9pp | 1.5%-1.0pp | 2.5% | N/A | N/A | N/A |
| Current Ratio | 1.47+0.0 | 1.440.0 | 1.43-0.1 | 1.49 | N/A | N/A | 1.40 |
| Debt-to-Equity | 0.37-0.1 | 0.48-0.1 | 0.59+0.2 | 0.41 | N/A | N/A | 0.37 |
| FCF Margin | 2.8%-1.4pp | 4.1%+0.6pp | 3.5%-0.2pp | 3.8%+1.1pp | 2.6%-0.4pp | 3.1% | N/A |
Similar Companies
Frequently Asked Questions
What is Celestica's annual revenue?
Celestica (CLS) reported $9.6B in total revenue for fiscal year 2024. This represents a 21.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Celestica's revenue growing?
Celestica (CLS) revenue grew by 21.2% year-over-year, from $8.0B to $9.6B in fiscal year 2024.
Is Celestica profitable?
Yes, Celestica (CLS) reported a net income of $428.0M in fiscal year 2024, with a net profit margin of 4.4%.
What is Celestica's earnings per share (EPS)?
Celestica (CLS) reported diluted earnings per share of $3.61 for fiscal year 2024. This represents a 77.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Celestica's EBITDA?
Celestica (CLS) had EBITDA of $751.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Celestica have?
As of fiscal year 2024, Celestica (CLS) had $423.3M in cash and equivalents against $770.2M in long-term debt.
What is Celestica's gross margin?
Celestica (CLS) had a gross margin of 10.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Celestica's operating margin?
Celestica (CLS) had an operating margin of 6.2% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Celestica's net profit margin?
Celestica (CLS) had a net profit margin of 4.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Celestica's return on equity (ROE)?
Celestica (CLS) has a return on equity of 22.6% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Celestica's free cash flow?
Celestica (CLS) generated $303.0M in free cash flow during fiscal year 2024. This represents a 50.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Celestica's operating cash flow?
Celestica (CLS) generated $473.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Celestica's total assets?
Celestica (CLS) had $6.0B in total assets as of fiscal year 2024, including both current and long-term assets.
What are Celestica's capital expenditures?
Celestica (CLS) invested $170.9M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Celestica spend on research and development?
Celestica (CLS) invested $78.0M in research and development during fiscal year 2024.
Does Celestica buy back shares?
Yes, Celestica (CLS) spent $152.0M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
What is Celestica's current ratio?
Celestica (CLS) had a current ratio of 1.49 as of fiscal year 2024, which is considered adequate.
What is Celestica's debt-to-equity ratio?
Celestica (CLS) had a debt-to-equity ratio of 0.41 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Celestica's return on assets (ROA)?
Celestica (CLS) had a return on assets of 7.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Celestica's Altman Z-Score?
Celestica (CLS) has an Altman Z-Score of 7.05, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Celestica's Piotroski F-Score?
Celestica (CLS) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Celestica's earnings high quality?
Celestica (CLS) has an earnings quality ratio of 1.11x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Celestica cover its interest payments?
Celestica (CLS) has an interest coverage ratio of 11.5x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Celestica?
Celestica (CLS) scores 60 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.